Trelegy ellipta 200-62.5-25 60S
Ended Awarded
- Contract number
- SPE2DB25FR9QL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $45,640
Award facts
- Contract value 100% obligated
- $45,640.37 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $45,640.37 to AmerisourceBergen Drug Corp for the supply of Trelegy Ellipta 200-62.5-25, a combination inhalation powder used in the treatment of chronic obstructive pulmonary disease. The contract, awarded on August 6, 2025, with an ultimate completion date of August 7, 2025, was competitively procured without a set-aside designation and is structured as a firm fixed-price delivery order. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
This delivery order is executed under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle running through December 2026 that serves as the primary pharmaceutical supply mechanism for military healthcare systems globally. As a major pharmaceutical distributor, AmerisourceBergen supports the Defense Health Agency and other federal healthcare entities through comprehensive product portfolios spanning brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The company's extensive experience fulfilling federal medical procurement requirements through competitive awards demonstrates its capability to meet the critical pharmaceutical supply needs of the military health system.
Quick answers
Who was awarded contract SPE2DB25FR9QL?
SPE2DB25FR9QL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 6, 2025.
How much is contract SPE2DB25FR9QL worth?
The government has obligated $45,640 on SPE2DB25FR9QL.
Is contract SPE2DB25FR9QL an order under another contract?
Yes. SPE2DB25FR9QL is a delivery order under SPE2DB22D2103, an indefinite delivery contract.
Was contract SPE2DB25FR9QL competed?
The extent of competition for SPE2DB25FR9QL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award